GOALS OF WORK: This study assessed the impact of acculturation on the prevalence of traditional Chinese medicine and other complementary and alternative medicine (TCM/CAM) use in newly diagnosed Chinese cancer patients. The individual determinants of TCM/CAM use among patients were also investigated. MATERIALS AND METHODS: A consecutive sample of Chinese cancer patients treated at the British Columbia Cancer Agency was surveyed at admission using a 15-item questionnaire. Items included TCM/CAM use, sociodemographics, as well as medical and cultural factors. Data were analyzed using bivariate methods including Pearson's X (2) test and Student's t test. As well, multiple logistic regression was used to obtain the final causal model. MAIN RESULTS: Of the 230 respondents, 57% completed the survey in Chinese and 94% were immigrants. The average age was 59. Participants had a mean disease duration of approximately 2 months and 79% had already received at least one conventional treatment. Overall, TCM/CAM was used by 47% of respondents. Herbal remedies, vitamins/minerals, and prayer were the most commonly used therapies. Multivariable analysis showed that prior TCM/CAM use (p < 0.001), having received conventional treatment(s) (p = 0.029), and being less acculturated (p = 0.028) were associated with TCM/CAM use. CONCLUSIONS: Prevalence and type of use were found to vary as a function of the degree of acculturation. Health care practitioners would be well advised to discuss TCM/CAM use with their patients, especially those who are less acculturated to Western society, since they are the most likely users of TCM/CAM.
GOALS OF WORK: This study assessed the impact of acculturation on the prevalence of traditional Chinese medicine and other complementary and alternative medicine (TCM/CAM) use in newly diagnosed Chinese cancerpatients. The individual determinants of TCM/CAM use among patients were also investigated. MATERIALS AND METHODS: A consecutive sample of Chinese cancerpatients treated at the British Columbia Cancer Agency was surveyed at admission using a 15-item questionnaire. Items included TCM/CAM use, sociodemographics, as well as medical and cultural factors. Data were analyzed using bivariate methods including Pearson's X (2) test and Student's t test. As well, multiple logistic regression was used to obtain the final causal model. MAIN RESULTS: Of the 230 respondents, 57% completed the survey in Chinese and 94% were immigrants. The average age was 59. Participants had a mean disease duration of approximately 2 months and 79% had already received at least one conventional treatment. Overall, TCM/CAM was used by 47% of respondents. Herbal remedies, vitamins/minerals, and prayer were the most commonly used therapies. Multivariable analysis showed that prior TCM/CAM use (p < 0.001), having received conventional treatment(s) (p = 0.029), and being less acculturated (p = 0.028) were associated with TCM/CAM use. CONCLUSIONS: Prevalence and type of use were found to vary as a function of the degree of acculturation. Health care practitioners would be well advised to discuss TCM/CAM use with their patients, especially those who are less acculturated to Western society, since they are the most likely users of TCM/CAM.
Authors: Suzanne C Tough; David W Johnston; Marja J Verhoef; Keith Arthur; Heather Bryant Journal: Altern Ther Health Med Date: 2002 Mar-Apr Impact factor: 1.305
Authors: Vincent C H Chung; Polly H X Ma; Chun Hong Lau; Samuel Y S Wong; Eng Kiong Yeoh; Sian M Griffiths Journal: Health Expect Date: 2012-05-31 Impact factor: 3.377
Authors: Lisa Watt; Sonia Gulati; Nicola T Shaw; Lillian Sung; David Dix; Iraj Poureslami; Anne F Klassen Journal: Support Care Cancer Date: 2011-02-12 Impact factor: 3.603
Authors: Lynda G Balneaves; M E Wong; A J Porcino; T L O Truant; S E Thorne; S T Wong Journal: Support Care Cancer Date: 2018-06-03 Impact factor: 3.603
Authors: John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki Journal: Evid Based Complement Alternat Med Date: 2021-05-17 Impact factor: 2.650